Integration of capecitabine (X) into adjuvant therapy comprising docetaxel (T) followed by 5-FU, epirubicin, and cyclophosphamide (CEF): Efficacy in patients with triple-negative breast cancer (BC).Heikki Joensuu, Henrik Lindman, Riikka Huovinen et al.|Journal of Clinical Oncology|2010Cited by 6